These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 12784349

  • 1. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T, Nakayama Y, Nakamoto S, Kato S, Imai R, Nonaka T, Ishikawa H, Harashima K, Suzuki Y.
    Cancer; 2003 Jun 15; 97(12):3114-20. PubMed ID: 12784349
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ.
    Gynecol Oncol; 1997 Mar 15; 64(3):418-24. PubMed ID: 9062143
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 4. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
    Micke O, Prott FJ, Schäfer U, Tangerding S, Pötter R, Willich N.
    Anticancer Res; 2000 Nov 15; 20(6D):5113-5. PubMed ID: 11326679
    [Abstract] [Full Text] [Related]

  • 5. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M, Nagai Y, Inamine M, Kamiyama K, Ogawa K, Toita T, Murayama S, Aoki Y.
    Gynecol Oncol; 2008 Jan 15; 108(1):126-9. PubMed ID: 17936344
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):492-9. PubMed ID: 15925454
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.
    J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK, Wu LY, Sun YC, Li B, Zhang HT.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 01; 43(1):13-7. PubMed ID: 18366925
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A, Nakano T, Morita S, Oka K.
    Anticancer Res; 1999 Jan 01; 19(1B):829-36. PubMed ID: 10216501
    [Abstract] [Full Text] [Related]

  • 13. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y, Liang LZ, Zheng M, Wei M, Shen Y.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan 01; 42(1):29-33. PubMed ID: 17331418
    [Abstract] [Full Text] [Related]

  • 14. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):249-57. PubMed ID: 15337563
    [Abstract] [Full Text] [Related]

  • 15. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G.
    Gynecol Oncol; 1995 Mar 01; 56(3):402-5. PubMed ID: 7535720
    [Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
    Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T.
    J Gastroenterol Hepatol; 2007 May 01; 22(5):715-9. PubMed ID: 17444861
    [Abstract] [Full Text] [Related]

  • 17. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H, Schwörer D, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1989 Mar 01; 49(3):266-71. PubMed ID: 2721888
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
    Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS.
    Gynecol Oncol; 2012 Jan 01; 124(1):92-7. PubMed ID: 22014631
    [Abstract] [Full Text] [Related]

  • 19. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA, Doering DL, Bosscher JR, Day TG, Rao CV, Owens K, Kelly B, Goldsmith J.
    Gynecol Oncol; 1994 Nov 01; 55(2):169-73. PubMed ID: 7959279
    [Abstract] [Full Text] [Related]

  • 20. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
    Massuger LF, Koper NP, Thomas CM, Dom KE, Schijf CP.
    Gynecol Oncol; 1997 Mar 01; 64(3):473-6. PubMed ID: 9062153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.